Tower Research Capital LLC (Trc) Cytokinetics Inc Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Cytokinetics Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 16,920 shares of CYTK stock, worth $727,390. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,920
Previous 9,056
86.84%
Holding current value
$727,390
Previous $478,000
66.32%
% of portfolio
0.02%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding CYTK
# of Institutions
396Shares Held
114MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$631 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$512 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$462 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$265 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$122 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.05B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...